One-hour paclitaxel plus carboplatin for advanced non-small-cell lung cancer

ONCOLOGY

Volumn 12, Issue 1 SUPPL. 2, 1998, Pages 71-73

  Anthony Greco, F ^a   Hainsworth, John D ^a  

^a Sarah Cannon Minnie Pearl Cancer C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CIMETIDINE; CISPLATIN; COLONY STIMULATING FACTOR; DEXAMETHASONE; DIPHENHYDRAMINE; PACLITAXEL;

ADULT; AREA UNDER THE CURVE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; TREATMENT OUTCOME;

EID: 6844258193     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Hainsworth JD, Raefsky EL, Greco FA: Paclitaxel administered by a 1-hour infusion: A phase I/I1 trial comparing two schedules. Cancer J Sci Am 1-281-287, 1995.
2. Hainsworth JD, Greco FA: Paclitaxel administered by 1-hour infusion: Preliminary results of a phase I/II trial comparing two schedules. Cancer 74:1377-1382, 1994.
3. Hainsworth JD, Thompson DS, Greco FA: Paclitaxel by 1-hour infusion: An active drug in metastatic non-small-cell lung cancer. J Clin Oncol 13:1609-1614, 1995.
4. Chang AY, Kim K, Glick J, et al: Phase II study of Taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer The Eastern Cooperative Oncology Group results. J Natl Cancer Inst 85:388-394, 1993.
5. Murphy WK, Fossella FV, Winn RJ, et al: Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst 85:384-388, 1993.
6. Vafai D, Israel V, Zaretsky S, et al. Phase I/ II trial of combination carboplatin and Taxol in non-small-cell lung cancer (abstract). Proc Am Soc Clin Oncol 14:352, 1995.
7. Langer CJ, Leighton JC, Comis RL, et al Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: A phase II toxtcity, response, and survival analysis. J Clin Oncol 13:1860-1870, 1995.
8. Schutte W, Bork I, Sucker S. Phase II trial of paclitaxel and carboplatin as first-line treatment in advanced non-small cell lung cancer (abstract). Proc Am Soc Clin Oncol 15:398, 1996.
9. Langer C, Kaplan R, Roswald E, et al: Paclitaxel by 1-hour infusion combined with carboplatin in advanced non-small-cell lung carcinoma (NSCLC): A phase II study (abstract). Proc Am Soc Clin Oncol 15:396, 1996.
10. Johnson DH, Paul DM, Hande KR, et al: Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: A phase II trial. J Clin Oncol 14:2054-2060, 1996.
11. Ros V, Conner A, Mitchell RB: Carboplatin and paclitaxel for chemotherapy-naive patients with advanced non-small-cell lung cancer (abstract). Proc Am Soc Clin Ontol 15:404, 1996.
12. Bonomi P, Kim K, Chang A, et al: Phase III trial comparing etoposide (E) cisplatin (C) versus Taxol (T) with cisplatin-GCSF (G) versus Taxol-cisplatin in advanced non-small-cell lung cancer: An Eastern Cooperative Oncology Group trial (abstract). Proc Am Soc Clin Oncol 15:382, 1996.